Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer
- PMID: 4064348
- DOI: 10.1111/j.1365-2265.1985.tb01098.x
Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer
Abstract
To assess the significance of a single serum thyroglobulin (Tg) determination on and off thyroid suppressive therapy, serum Tg measurements have been performed in 349 serum samples from 82 patients with differentiated thyroid cancer. All samples were collected after total thyroidectomy with or without subsequent ablation of residual thyroid tissue by radioiodine. One hundred and fifty-three samples were obtained while the patients were on thyroid suppressive therapy and 196 after withdrawal of medication. The results of serum Tg assays were analysed in relation to the presence or absence of residual or metastatic thyroid tissue, as assessed by clinical and laboratory evaluation, including 131I whole body scan. In patients with thyroid residue but no metastases, undetectable serum Tg (false negative results) occurred in 45% of cases off therapy and in 92.9% of cases during therapy. In the presence of metastases no undetectable serum Tg result was found in patients off therapy, while four (6.9%) out of 58 samples from patients with bone and/or lung metastases and seven (31.8%) out of 22 samples from patients with lymph node metastases alone were undetectable (falsely negative) during suppressive therapy. Serum Tg was undetectable in sera from patients with no evidence of thyroid residue or metastatic disease in all but one (1.7%) of 59 samples on and three (5.4%) of 56 samples off suppressive therapy. These Tg results were confirmed to be truly rather than falsely positive, since evidence of metastatic disease was obtained by whole body scan after the administration of therapeutic doses of 131I.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
[Predictive value of serum thyroglobulin and diagnostic imaging in post-surgical follow-up of differentiated thyroid cancer].Nihon Rinsho. 2007 Nov;65(11):2069-72. Nihon Rinsho. 2007. PMID: 18018572 Review. Japanese.
-
Follow-up of differentiated thyroid carcinoma.Minerva Endocrinol. 2004 Dec;29(4):161-74. Minerva Endocrinol. 2004. PMID: 15765026 Review. English, Italian.
-
Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.Eur J Nucl Med Mol Imaging. 2002 Jun;29(6):768-74. doi: 10.1007/s00259-002-0781-x. Epub 2002 Mar 13. Eur J Nucl Med Mol Imaging. 2002. PMID: 12029550
-
Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.J Endocrinol Invest. 2002 Feb;25(2):110-5. doi: 10.1007/BF03343973. J Endocrinol Invest. 2002. PMID: 11929080
-
99mTc-sestamibi and 131I whole-body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma.J Nucl Med. 2000 Apr;41(4):631-5. J Nucl Med. 2000. PMID: 10768563
Cited by
-
Optimization of Predictive Performance for the Therapeutic Response Using Iodine Scan-Corrected Serum Thyroglobulin in Patients with Differentiated Thyroid Carcinoma.Cancers (Basel). 2020 Jan 22;12(2):262. doi: 10.3390/cancers12020262. Cancers (Basel). 2020. PMID: 31978980 Free PMC article.
-
Significance of micrometastases in the calculation of the lymph node ratio for papillary thyroid cancer.Ann Surg Treat Res. 2017 Mar;92(3):117-122. doi: 10.4174/astr.2017.92.3.117. Epub 2017 Feb 24. Ann Surg Treat Res. 2017. PMID: 28289664 Free PMC article.
-
Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.Int J Clin Oncol. 2016 Oct;21(5):862-868. doi: 10.1007/s10147-016-0956-2. Epub 2016 Feb 2. Int J Clin Oncol. 2016. PMID: 26837274
-
Robotic thyroidectomy by bilateral axillo-breast approach: review of 1,026 cases and surgical completeness.Surg Endosc. 2013 Aug;27(8):2955-62. doi: 10.1007/s00464-013-2863-1. Epub 2013 Feb 23. Surg Endosc. 2013. PMID: 23436099
-
To treat or not to treat: the role of adjuvant radioiodine therapy in thyroid cancer patients.J Oncol. 2012;2012:707156. doi: 10.1155/2012/707156. Epub 2012 Nov 1. J Oncol. 2012. PMID: 23193402 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous